The risk on trade, which essentially means taking exposure to the riskier asset class started once again. In India, this meant that once ag...

Indian retail investors, especially after the Covid pandemic, have changed their investment approach. There has been a significant bolsteri...

Banking and metal stocks lifted the market.

Stellar performances by the debutants and solid buoyancy in the sugar counters stole the show.

The offer for sale opened for subscription for non-retail investors and was subscribed 1.36 per cent so far. Retail investors can bid for t...

Dhanuka, which took over the pharma company under the NCLT resolution process in 2018, announced selling 32.80 lakh shares representing an ...

An Alvarez & Marsal India report on Thursday called upon all IBC stakeholders to focus on improving efficiency to resolve cases in a time-b...

Concerns on the asset quality front continue to persist for many lenders despite recent signs of abating stress.

One can buy shares of acquirers in the firms as NCLT cases could see a 40-70% haircuts.

Here's a look at the major movers and shakers of D-Street through the session.

Most experts said regulatory hurdles are going to be the biggest overhang for the sector and, hence, investors should remain selective.

The Nifty index was trading near its crucial psychological level of 7550, weighed down by losses in capital goods, autos, FMCG and pharma s...

The Department of Industrial Policy and Promotion (DIPP) has put the brakes on US-based Mylan Inc’s plan to acquire Agila Specialties.

There is no commitment of retail investors & much lesser leverage in India & worldwide as compared to 2008 says Big Bull Rakesh Jhunjhunwal...

In an interview with ET, Lupin's group president Shakti Chakraborty says recent acquisitions defied logic.

US-based drug giant Sepracor Inc and the University of Massachusetts have filed a patent infringement suit with the US district court of Ne...

The high-profile Mylan-Matrix deal is likely to trigger a series of mergers and acquisitions (M&A) in the Indian pharmaceutical market. Aro...